Smith, MD, Co-Investigator – Dr. Smith is a Radiation Oncologist who is responsible for radiation therapy of men with prostate cancer. He will assist in the recruitment and care of patients in the trial. Michael O’Donnell, MD, Co-Investigator – Dr. O’Donnell is an urologist at the UIHC who will contribute to the recruitment of new patients and care of enrolled patients in the study. Sundeep Deorah, MD, Co-Investigator – Dr. Deorah is an urologist at the UIHC who will contribute to the recruitment of new patients and care of enrolled patients in the study. Amit Gupta, MD, Co-Investigator – Dr. Gupta is an urologist at the UIHC who will contribute to the recruitment of new patients and care of enrolled patients in the study. Kenneth Nepple, MD, Co-Investigator – Dr. Nepple is an urologist at the UIH C who will contribute to the recruitment of new patients and care of enrolled patients in the study. Pamela Zehr, RN, MA - Clinical Trial Coordinator – Ms. Zehr participates in clinical trials in the Holden Comprehensive Cancer Center at the University of Iowa. She has and will continue to guide the clinical protocol through the institutional and federal other regulatory approval processes . She will coordinate follow -up visits of the patients. Mary S chall, RN – Clinical Trial Coordinator - Ms. S chall also participates in clinical trials in the Holden Comprehensive Cancer Center at the University of Iowa. She will act as a backup for Ms. Zehr. Karen Clark Griffith , RN, PhD - Clinical Trial Coordinator VAMC – Ms. Griffith will be responsible for trial for Veteran patients enrolled in the clinical trial at the VA Health Care System . She will work closely with all members of the trial team and attend the weekly meetings to discuss eligibility and follow -up of patients. Lubaroff Ad/PSA Phase II, protocol #2, page 32 Steven Varga, PhD, Collaborator – Dr. Varga is an immunologist and will assist in the immunologic evaluation of patient’s immune responses to the vaccine. Lyse Norian, PhD, Collaborator – Dr. Norian is an immunologist and will assist in the immunologic evaluation of patient’s immune responses to the vaccine. Gideon Zamba, PhD – Biostatistician – Dr. Zamba participated in the discussions pertinent to the development of the clinical protocols, performed the power analysis, and constructed the section on statistical considerations for the trial. He will assist in the data analysis and statistical interpretation of the patient data. LITERATURE REFERENCES 1. Jemal, A, Siegel, R Ward, E, Murray, T, Xu, J, Smigal, C, and Thun, MJ. Cancer Statistics 2006. CA Cancer J Clin, 56:106-130, 2006. 2.